Apoptotic threshold is lowered by p53 transactivation of caspase-6

Little is known about how a cell's apoptotic threshold is controlled after exposure to chemotherapy, although the p53 tumor suppressor has been implicated. We identified executioner caspase-6 as a transcriptional target of p53. The mechanism involves DNA binding by p53 to the third intron of the caspase-6 gene and transactivation. A p53-dependent increase in procaspase-6 protein level allows for an increase in caspase-6 activity and caspase-6-specific Lamin A cleavage in response to Adriamycin exposure. Specific inhibition of caspase-6 blocks cell death in a manner that correlates with caspase-6 mRNA induction by p53 and enhances long-term survival in response to a p53-mediated apoptotic signal. Caspase-6 is an executioner caspase found directly regulated by p53, and the most downstream component of the death pathway controlled by p53. The induction of caspase-6 expression lowers the cell death threshold in response to apoptotic signals that activate caspase-6. Our results provide a potential mechanism of lowering the death threshold, which could be important for chemosensitization.

[1]  C. Harris,et al.  APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. , 2001, Cancer research.

[2]  I. Mian,et al.  SATB1 Cleavage by Caspase 6 Disrupts PDZ Domain-Mediated Dimerization, Causing Detachment from Chromatin Early in T-Cell Apoptosis , 2001, Molecular and Cellular Biology.

[3]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[4]  S. Srinivasula,et al.  Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. , 2001, Cancer research.

[5]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[6]  Sanjeev Gupta,et al.  Direct Transcriptional Activation of Human Caspase-1 by Tumor Suppressor p53* , 2001, The Journal of Biological Chemistry.

[7]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[8]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[9]  A. Maitra,et al.  Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. , 2001, Human pathology.

[10]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[11]  L. Denner,et al.  3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9. , 2000, Biochemical pharmacology.

[12]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[13]  S. Zhuang,et al.  Peroxynitrite-induced apoptosis involves activation of multiple caspases in HL-60 cells. , 2000, American journal of physiology. Cell physiology.

[14]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[15]  N. Thornberry,et al.  Determination of caspase specificities using a peptide combinatorial library. , 2000, Methods in enzymology.

[16]  R. Flavell,et al.  Caspase knockouts: matters of life and death , 1999, Cell Death and Differentiation.

[17]  C. Bergeron,et al.  Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.

[18]  K. Uzawa,et al.  Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25 , 1999, Oncogene.

[19]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[20]  J. Minna,et al.  Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. , 1998, Cancer research.

[21]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[22]  S. Yonehara,et al.  Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis , 1998, The Journal of experimental medicine.

[23]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[24]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[25]  A. Porter,et al.  Death substrates come alive , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  Seamus J. Martin,et al.  Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death* , 1997, The Journal of Biological Chemistry.

[27]  N. Thornberry.  The caspase family of cysteine proteases. , 1997, British medical bulletin.

[28]  E. White,et al.  Lamin proteolysis facilitates nuclear events during apoptosis , 1996, The Journal of cell biology.

[29]  T. Jacks,et al.  Loss of Rb activates both p53‐dependent and independent cell death pathways in the developing mouse nervous system. , 1996, The EMBO journal.

[30]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[31]  W. El-Deiry,et al.  Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[33]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[34]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.